BlackRock’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,380,477
Closed -$13.5M 5624
2025
Q3
$13.5M Buy
2,380,477
+169,161
+8% +$866K ﹤0.01% 3292
2025
Q2
$8.43M Sell
2,211,316
-145,496
-6% -$452K ﹤0.01% 3495
2025
Q1
$6.2M Buy
2,356,812
+73,639
+3% +$240K ﹤0.01% 3553
2024
Q4
$8.08M Buy
2,283,173
+429,424
+23% +$1.64M ﹤0.01% 3532
2024
Q3
$8.45M Buy
1,853,749
+85,080
+5% +$412K ﹤0.01% 3492
2024
Q2
$7.69M Sell
1,768,669
-32,941
-2% -$145K ﹤0.01% 3520
2024
Q1
$9.04M Sell
1,801,610
-61,829
-3% -$346K ﹤0.01% 3395
2023
Q4
$11.7M Buy
1,863,439
+134,319
+8% +$769K ﹤0.01% 3318
2023
Q3
$12.3M Sell
1,729,120
-308
-0% -$2.43K ﹤0.01% 3211
2023
Q2
$17.6M Buy
1,729,428
+1,617,539
+1,446% +$16.9M ﹤0.01% 3117
2023
Q1
$1.01M Buy
111,889
+47,727
+74% +$350K ﹤0.01% 4331
2022
Q4
$460K Sell
64,162
-640
-1% -$3.91K ﹤0.01% 4626
2022
Q3
$422K Buy
64,802
+14
+0% +$75 ﹤0.01% 4774
2022
Q2
$313K Buy
64,788
+6,905
+12% +$34.2K ﹤0.01% 4911
2022
Q1
$329K Sell
57,883
-1,602
-3% -$7.87K ﹤0.01% 4988
2021
Q4
$298K Buy
59,485
+1,380
+2% +$7.59K ﹤0.01% 5010
2021
Q3
$387K Sell
58,105
-4,092
-7% -$24.5K ﹤0.01% 4829
2021
Q2
$380K Sell
62,197
-266,972
-81% -$1.61M ﹤0.01% 4759
2021
Q1
$2.19M Buy
329,169
+6,866
+2% +$47.1K ﹤0.01% 4262
2020
Q4
$1.71M Buy
322,303
+62,827
+24% +$492K ﹤0.01% 4085
2020
Q3
$1.93M Buy
259,476
+1,116
+0.4% +$8.72K ﹤0.01% 3911
2020
Q2
$1.9M Buy
258,360
+238,148
+1,178% +$2.09M ﹤0.01% 3834
2020
Q1
$150K Buy
20,212
+316
+2% +$2.29K ﹤0.01% 4280
2019
Q4
$112K Buy
19,896
+2,306
+13% +$11.8K ﹤0.01% 4426
2019
Q3
$104K Sell
17,590
-990
-5% -$5.58K ﹤0.01% 4436
2019
Q2
$60K Sell
18,580
-326,307
-95% -$1.07M ﹤0.01% 4559
2019
Q1
$1.03M Sell
344,887
-13,356
-4% -$45.9K ﹤0.01% 3900
2018
Q4
$1.35M Buy
358,243
+7,094
+2% +$33.3K ﹤0.01% 3791
2018
Q3
$2.06M Buy
351,149
+3,063
+0.9% +$15.6K ﹤0.01% 3764
2018
Q2
$1.97M Buy
348,086
+59,617
+21% +$613K ﹤0.01% 3744
2018
Q1
$3.58M Buy
288,469
+287,105
+21,049% +$3.86M ﹤0.01% 3523
2017
Q4
$16K Buy
+1,364
New +$19.3K ﹤0.01% 4595